12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

ReNeuron, Cell Therapy Catapult (CTC) deal

ReNeuron partnered with CTC to develop and optimize the processes required to scale up manufacture of ReNeuron's CTXcell line, including rapid cell culture techniques, cryopreservation and protocols for automated manufacturing. The partners will also work...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >